Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MIAMI LAKES, Fla. , July 19, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP), (www.fusescience.com) an innovative consumer products company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, is pleased to announce that National Physique Committee Champion Michelle Ray will be demonstrating what it means to be "Powered by Fuse™" on CBS -affiliate KENS-TV on Saturday, July 21st at 8:15 AM CT .
(Photo: http://photos.prnewswire.com/prnh/20120719/NY42942 )
The live broadcast will feature Ray's tips and demonstrations regarding effective workouts as well as preventing fitness fatigue utilizing EnerJel™ to help address site-specific muscle exhaustion.
"The main reason most people end up skipping workouts or not working out hard is muscle fatigue, pain and soreness from their last workout. This affects people from all walks of life whether you are a weekend warrior or a serious fitness athlete. That is where EnerJel™ is going to make a huge difference. What I have found is whenever I am stiff and sore and my muscles are fatigued, I rub EnerJel™ on those areas, and within 5 minutes, the soreness and pain are gone, and I'm able to push thru and get an amazing workout!", stated Ray.
Brian Tuffin , Fuse Science CEO stated: "There is a reason that Michelle has won first place in her first two major competitions. She is known for her hard core training methods and being Powered by Fuse allows her to always bring her A game. We are excited to have Michelle share how integrating EnerJel into her workout allows her to stay on top of her game."
For those unable to view the show live, the video should be available on the KENS-TV web site, www.kens5.com shortly after broadcast and it will be posted on the Fuse Science web site, www.poweredbyfuse.com early next week.
Thanks for the update JackH...but what impact will this have on the suckers like me who bought this a few months ago?
Tigerfuse: I'd give up all of my rounds in the 70's for DROP to get above $2.00 :)
Takeachance...From Rochester to Atlanta here...
ok..i give up...all I know is that I googled it and came up with some Amazon reviews...sorry to waste your time all
Sorry all...bad link..
www.amazon.com/Powered-By-Fuse-Enerjel/.../B006U5WHXC
Hey Scooter...I'm hoping the reviews of EnerJel users will help in its effort to get the word out. I know I, as well as many other consumers, tend to look at purchasers' reviews when making a first time purchase of anything now days...Although I'm not familiar with what the latest situation with Amazon, here are some testimonials of EnerJel users. Whether its Amazon or a number of other internet distribution channels, most tend to have a customer review of the product. Nothing beats word of mouth advertising and I'm hoping this type information out there will help stimulate its growth..
[url][/url][tag]http://www.amazon.com/Powered-By-Fuse-Enerjel/product-reviews/B006U5WHXC[/tag]
pescatom...hey, it was a lot better effort than i've ever made :) wasn't trying to be too critical...
Too much of a Gatorade look...IMO
Nicely done Shore,
And..this is the technology and potential that I'm most excited about...People looking at Tiger's bag with the Fuse logo have no idea about the most powerful and still somewhat most overlooked aspect of this stock..(except for the savvy individuals on this board)...IMO although EnerJel offers a unique quality in its category of product, I think it will be dwarfed by the success of its sibling it will soon be supporting...chills up my spine here..
Infoseeker..are just trying to bait me with that spelling of Energel? LOL
Just had to tell you all how badly I got "psyched" last night...watching the golf channel...and an ad comes on with Tiger running...coming to a stop...hands on knees...and I'm thinking, here it comes...and ad for Enerjel...close up on the running shoes..and then yes...you guessed it...from running shoes...to Nikes' new golf shoes...DAMN!!!! LOL..Oh well maybe next time...GLTA
Nice!
It's called managing the brand
Not expecting a response...but I'll let everyone know...
I sent them an email...but doubt I'll get a response...
Which goes directly to the point of why I wasn't excited to see a private labled GNC product by the name of "Energel" on the stores'shelves. If you have a GNC franchise owner spellng Enerjel incorrectly, what do you think the general public is going to do in their initial searches? probably or hoping that it would only be a minimal loss in early sales...but, still don't like it..
"GNC has spent millions in software to predict the impact of Enerjel in their category for that space..." ??? I find it hard to believe that GNC spent "millions in software" for one sku that will occupy it's stores' shelf space...Believe me, I'm long in this stock...but I'd like you to substantiate that claim...
I'm out too!! Will keep on the watch list, but just losing money here....
hope you're right.... long here!
Would have preferred that some private label product from GNC even though spelled differently, but having the exact same pronunciation as Enerjel...not be on their shelves...you know...Marketing 101?
Not exactly liking this...
http://gnc.imageg.net/graphics/product_images/pGNC1-2437375t300x300.jpg
Home / Sports Nutrition / GNC Sports / GNC Pro Performance® EnerGel - Orange
Zoom
GNC Pro Performance® EnerGel - Orange
24 Packets
497768
Price: was $30.96 Now $21.97
With Gold Card Purchase: $17.58 Details
$4.99 Flat Rate Shipping on RTDs & Stacks!Details
Be the first to Write a Review
QTY: Add to Cart
AVAILABILITY: BACKORDER Leaves warehouse in 1-2 weeks Details
DESCRIPTION
Helps boost and sustain energy.
30 Grams of Quadra Carb Blend featuring maltodextrin, fructose, glycerine and ribose.
Fast absorbing gel.
Great for hikers and bikers.
Limited distribution, may not be available in all areas.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
SUPPLEMENT FACTS
HEALTH NOTES
RATINGS AND REVIEWS
ASK A QUESTION
....and the planets are perfectly in line...lol...long here...
COLORADO SPRINGS, Colo. --(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is excited to announce that it has created the "Cannabis Science Research Foundation". The Cannabis Science Research Foundation is a new source of hope for a world where numerous critical medical conditions affect millions of people in the United States alone, and do not have satisfactory treatment options. This Foundation will be unique in that it is dedicated to bring new findings about the endocannabinoid system and how phytocannabinoids can modulate it's activity with the aim of facilitating the translational work necessary for widespread medical implementation.
The Foundation will be funded internally and externally through donations, and fundraising charity events, such as charity black tie events, fundraising dinner events, concerts, movie showings, documentaries, etc.
The company realizes that in order to bring cannabis-based medications and remedies to the mainstream market, extensive research is necessary. The Foundation will target numerous critical ailments Cannabis Science has identified by working with patients in medical cannabis states. Our patient oriented research helps us in determining appropriate treatments and guides Cannabis Science's development of new products for each of the Company's targeted national and international distribution markets. Of course, all of your efforts move the Company closer to entering the FDA to perform federally approved clinical studies so that medical claims can be justified.
The initial focus of the Foundation will begin with cancer treatment. The Company has already reported the apparent success with self-medicated cancer patients using its formulations on basal and squamous cell carcinomas (please see the website at www.cannabisscience.com and click on "Breaking News"). These findings have spearheaded more cancer research necessary for understanding the influence cannabis can have on the illness. Additional research will be supplemented by the Foundation.
All the funds raised in the Foundation will provide the financial strength to support research efforts, including new developments that will be announced soon.
In addition to research, advocacy and education are fundamental parts of the Foundation's mission. The current conventional medical industry lacks a holistic understanding about the endocannabinoid system and the benefits cannabis has for those who are ill. Through education, the Foundation hopes to change the mainstream view of cannabis and create a standard for developing safe, effective medications that will be the model for what cannabis medicine can be. The foundation's board of directors, currently being assembled, will bring together experience and knowledge in the relevant scientific, financial, regulatory and political fields of medical cannabis. The Cannabis Science Research Foundation hopes that you will follow and contribute to our development by coming on board and donating to this exciting and much needed cause.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
CONTACT: Cannabis Science Inc.
Dr. Robert J. Melamede
President & CEO
1-888-889-0888
info@cannabisscience.com
www.cannabisscience.com
or
Robert Kane
VP Investor Relations
1-561-234-6929
rkane@cannabisscience.com
info@cannabisscience.com
www.cannabisscience.com
Source: Cannabis Science, Inc.
Me too Info...Rochester!
Why do you think the company owes you anything? Either you believe in what they are doing and invest....or you don't..THATS how simple it is...
Level II...not sure I know all there is with regard to Level II...but is what I'm looking at encouraging?
What A&E coverage?
Let's hope we see something other than what's on his golf bag
Just submitted a question on Tiger's Fitness Q&A portion of his website asking, "do you anticipate participating in any Fuse Science commercials or print media any time in the near future?"
What do you think the chances are of getting a response? LOL
I just had to get back in today at these levels...
Because he's shorting the stock
Hey bgrass!...I just sent them an email stating that fact...we'll see if we get a response...
Old news again!!!
Old News...
My thoughts exactly!!!
Wouldn't be my first choice...Jimi Hendrix...really?
Read my Happy 420!!! Post...New News!!
Happy 4/20 !!!
COLORADO SPRINGS, Colo. --(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to welcome Andrew Pitsicalis as International Brand and Licensing Director.
Mr. Pitsicalis has been CEO of Rockin Artwork since 2010. Rockin Artwork is an intellectual property company, which manages or owns images and art by artists for Licensing and Fine Art. Their works include those by Mike and Dasha Biggs , David Garibaldi , Justin Farano , Dan Kennedy and more. Leon Hendrix , Jimi Hendrix's brother, is an owner and the spiritual guide of the company and their collection includes Jimi Hendrix images and art for merchandise and licensing.
Rockin Artwork has granted Cannabis Science a co-branding license to allow Cannabis Science to advertise, manufacture, and brand Jimi Hendrix images and likenesses and to make Jimi Hendrix image and likeness related products and the marketing thereof. Leon Hendrix is pleased to endorse Cannabis Sciences' role in creating great products his brother Jimi Hendrix would be proud of.
When asked his thoughts were joining Cannabis Science Inc. , Mr. Pitsicalis said, "I look forward to creating great quality products. Having experience licensing properties that span a fan base of 2 billion people worldwide, I have licensed products in mass market retail stores around the globe. You can find Pitsicalis' companies, licensed products in places like, Walmart, Target , Kohls, JC Penny, Urban Outfitters , Old Navy and other mass retail chains."
Mr. Pitsicalis's role at Cannabis Science is to help build the brands of Cannabis Science . This will include consulting and brand management of Cannabis Science product lines, manufacture and develop the licensing platform for Cannabis Science , Patents and Trademarks. Mr. Pitsicalis will facilitate the advertising and licensing of products and branding of Cannabis Science . Pitsicalis will be selecting advertising campaigns for brand and product recognition. There are plans in the future to eventually license our biotechnology to pharmaceutical companies and other hemp related manufacturing licenses. Andrew has extensive connections to doctors, intellectual property, and venues for future medical cannabis conferences, all of which are invaluable to Cannabis Science .
Mr. Pitsicalis, legal victories in Federal Court for Jimi Hendrix Intellectual property rights will give Cannabis Science a seasoned component to licensing and branding. Andrew will be seated on the Policy Advisory Board for the company and we are pleased to have his input from his legal and licensing knowledge.
Cannabis Science is excited to welcome another talented and professional individual into the fold and looks forward to the endless promotion opportunities available through Andrew Pitsicalis.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
www.cannabisscience.com
CONTACT: Cannabis Science Inc.
Dr. Robert J. Melamede
President & CEO
1-888-889-0888
info@cannabisscience.com
or
Robert Kane
Investor Relations Management
1-561-234-6929
rkane@cannabisscience.com
Source: Cannabis Science, Inc.
Unfortunately, this won't be a hot topic in any election season...